Table 1.

Combination therapy of cisplatin and other cancer drugs

Combination Drug(s)	Cancer Type	Reference(s)
Paclitaxel	Ovarian carcinoma Breast carcinoma Lung carcinoma Melanoma Head and neck carcinoma	Sarosy, Kohn et al., (1992) McGuire, Rowinsky et al., (1989) Einzig, Wiernik et al., (1992) Holmes, Walters et al., (1991) Murphy, Fossella et al., (1993) Legha, Ring et al., (1990) Einzig, Hochster et al., (1991) Forastiere, (1994)
Paclitaxel and 5-FU	Gastric and Esophagogastric adenocarcinoma	Kim, Shin et al., (1999)
UFT	Non small lung carcinoma	Ichinose, Yosimori et al., (2000)
Doxorubicin	Diffuse malignant pleural mesothelioma	Ardizzoni, Rosso et al., (1991)
Cyclophosphamide and doxorubicin	Salivary gland advanced carcinoma	Dreyfuss, Clark et al., (1987)
Gemcitabine	Biliary cancer	Valle, Wasan et al., (2010)
Osthole	Lung cancer	Xu, Zhang et al., (2013)
Honeybee venom	Ovarian cancer	Alizadehnohi, Nabiuni, Nazari, Safaeinejad, and Irian, (2012)
Anvirzel	Breast, Colon, Lung, Prostate, Melanoma and Pancreatic cancer	Apostolou, Toloudi et al., (2013)
Bevacizumab	Non small lung carcinoma	Du, Li et al., (2013)
Vinbalstine and bleomycin	Metastatic granulosa cell tumors in ovary	Colombo, Sessa et al., (1986)
Methotrexate and bleomycin	Advanced squamous cell carcinoma of the male genital tract	Dexeus, Logothetis et al., (1991)
Everolimus	Urothelial bladder cancer	Pinto-Leite, Arantes-Rodrigues et al., (2013)
Fluorouracil, doxorubicin and cyclophosphamide	Salivary gland carcinoma	Dimery, Legha et al., (1990)
Metformin	Lung adenocarcinoma	Lin, Yeh et al., (2013)
Oxaliplatin, quercetin and thymoquinone	Ovarian cancer	Nessa, Beale et al., (2011)
Olaparib	PTEN deficient Lung cancer	Minami, Takigawa et al., (2013)
Tetra arsenic oxide	Cervical cancer	Byun, Jeong et al., (2013)
Vindesine	Non small lung carcinoma	Le, Brisgand et al., (1994)
β-galactosyl-pyrrolidinyldiazeniumdiolate	Glial cells of brain Human cervical cancer Gliosarcoma cell lines	Deng, Zhang et al., (2013)